Francesca Blasco

Optimised method to estimate octanol water distribution coefficient (logD) in a high throughput format.

F. Blasco, Ying Wei Ivan Low, Francesca Blasco, 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Discovery and SAR of potent, orally available 2,8-diaryl-quinoxalines as a new class of JAK2 inhibitors.

Eric Vangrevelinghe, Clive McCarthy, Pascal Furet, 2010, Bioorganic & medicinal chemistry letters.

Design of novel aminopyrrolidine factor Xa inhibitors from a screening hit.

Martin Stahl, Jörg Benz, Daniel Schlatter, 2009, European journal of medicinal chemistry.

Implementation of pharmacokinetic and pharmacodynamic strategies in early research phases of drug discovery and development at Novartis Institute of Biomedical Research

Tove Tuntland, K. Hoffmaster, F. Blasco, 2014, Front. Pharmacol..

Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation.

Doriano Fabbro, Pascal Furet, Giorgio Caravatti, 2013, Bioorganic & medicinal chemistry letters.

2-Amino-aryl-7-aryl-benzoxazoles as potent, selective and orally available JAK2 inhibitors.

Eric Vangrevelinghe, Marc Lang, Pascal Furet, 2010, Bioorganic & medicinal chemistry letters.